İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

SONAY İNCESOY ÖZDEMİR

PROFESÖR

ANKARA ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Çocuk Hematolojisi ve Onkolojisi (Çocuk Sağlığı ve Hastalıkları)

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 64
  • Proje 0
  • Kitap 0
  • Bildiri 79
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 13 Q2 7 Q3 26 Q4 4
WoS (JCR) Q1 6 Q2 10 Q3 18 Q4 13
TR Index 18 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 2
Üst %10 makale 4
Ort. yüzdelik 52.2%
Üst %1 payı 4.2%
Üst %10 payı 8.3%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 64 yayın

Makale listesi

  1. 2026 Clinical spectrum and survival outcomes of malignancies in pediatric patients with inborn errors of immunity Frontiers in Immunology DOI 10.3389/fimmu.2026.1904173 YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.0%
  2. 2025 Primary Hemophagocytic Lymphohistiocytosis: A Severe Immune Dysregulatory Disease with Various Genotypic Features and Outcome: A Cross Sectional Study from Tertiary Pediatric Center Turk J Haematol DOI 10.4274/tjh.galenos.2025.2025.0221. YÖKSİS SJR Q3 JCR Q2 OpenAlex 79.4%
  3. 2025 Investigation of serum C-type natriuretic peptide concentration at diagnosis and remission in pediatric osteosarcomas European Journal of Pediatrics DOI 10.1007/s00431-024-05949-x YÖKSİS OpenAlex 66.1%
  4. 2025 Adherence to Oral Nutritional Support and Its Effect on Nutritional Status in Pediatric Oncology Patients Nutrition and Cancer DOI 10.1080/01635581.2025.2584473 YÖKSİS SJR Q2 JCR Q3 OpenAlex 43.1%
  5. 2025 Non-Hodgkin lymphomas in a Turkish pediatric cancer center: A developing-country model. Journal of Clinical Oncology DOI 10.1200/JCO.2025.43.16_suppl.e22002 YÖKSİS SJR Q1 JCR Q1
  6. 2024 Serum total oxidant and anti-oxidant status in children with cancer Journal of Cancer Research and Therapeutics DOI 10.4103/jcrt.jcrt_1948_22 YÖKSİS SJR Q2 JCR Q4 OpenAlex 12.9%
  7. 2024 Evaluation of late effects during a 21‑year follow‑up of pediatric Hodgkin lymphoma survivors: Experience of a pediatric cancer center in Turkey, as a developing country model Indian Journal of Cancer DOI 10.4103/ijc.IJC_912_20 YÖKSİS SJR Q3 JCR Q4 OpenAlex 62.2%
  8. 2024 Impact of COVID-19 Pandemic on Delay of Diagnosis and Treatment: Outcomes in Pediatric malignant solid tumors Türkiye Çocuk Hast Derg DOI 10.12956/tchd.1336555 YÖKSİS TR Index OpenAlex 46.9%
  9. 2024 De novo germline TP53 mutation in a pediatric patient with Li–Fraumeni syndrome and diffuse peritoneal mesothelioma Pediatric Blood & Cancer DOI 10.1002/pbc.31071 YÖKSİS SJR Q1 JCR Q2 OpenAlex 11.5%
  10. 2024 Clinical and Prognostic Characteristics in Childhood Osteosarcoma: A Single-Center Experience in Türkiye Turkish Archives of Pediatrics DOI 10.5152/TurkArchPediatr.2024.24043 YÖKSİS TR Index SJR Q3 JCR Q2 OpenAlex 58.2%
  11. 2023 Nivolumab for pediatric malignant peritoneal mesothelioma Pediatr Blood Cancer DOI 10.1002/pbc.29892 YÖKSİS SJR Q1 JCR Q1 OpenAlex 45.2%
  12. 2023 Orbital Alveolar Soft Part Sarcoma Misdiagnosed as Hemangioma in an Infant. Turkish archives of pediatrics DOI 10.5152/TurkArchPediatr.2022.22069 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 51.7%
  13. 2022 TRAMETINIB EXPERIENCE IN A BRAF P.N 486 _P490DEL MUTATION POSITIVE LANGERHANS CELL HISTIOCYTOSIS Hematology, Transfusion and Cell Therapy DOI 10.1016/j.htct.2022.09.1273 YÖKSİS SJR Q3 JCR Q3 OpenAlex 14.8%
  14. 2022 Clinical Profile and Outcomes of Primary Immunodeficiency and Malignancy in Childhood at a Tertiary Oncology Center in Developing Country Pediatric Hematology and Oncology DOI 10.1080/08880018.2022.2045408 YÖKSİS SJR Q3 JCR Q3 OpenAlex 66.2%
  15. 2022 SUCCINATE DEHYDROGENASE SUBUNIT B DEFICIENT PEDIATRIC GIST Hematology, Transfusion and Cell Therapy DOI 10.1016/j.htct.2022.09.1269 YÖKSİS SJR Q3 JCR Q3 OpenAlex 18.6%
  16. 2022 Late outcomes in children and adolescents with non‑Hodgkin lymphoma: A single‑center experience Journal of Cancer Research and Therapeutics DOI 10.4103/jcrt.jcrt_80_21 YÖKSİS SJR Q3 JCR Q4 OpenAlex 72.4%
  17. 2022 Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report Elsevier BV DOI 10.1016/j.phoj.2022.08.006 YÖKSİS SJR Q4 OpenAlex 45.1%
  18. 2022 IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT Elsevier BV DOI 10.1016/j.htct.2022.09.1229 YÖKSİS SJR Q3 JCR Q3 OpenAlex 16.8%
  19. 2022 Neutrophil-lymphocyte and Platelet-lymphocyte Ratios in Febrile Seizures Galenos Yayinevi DOI 10.4274/cayd.galenos.2021.25483 YÖKSİS TR Index OpenAlex 66.4%
  20. 2022 Çocukluk Çağı Kanserlerinde NTRK Somatik Füzyonları ve Tümör Agnostik Tedavi Cagdas Tip Dergisi: Journal of Contemporary Medicine DOI 10.16899/jcm.1113357 YÖKSİS OpenAlex 43.5%

Akademisyenlere dön